Patents by Inventor Hugh Jeffrey Lawrence

Hugh Jeffrey Lawrence has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Algorithms and Methods for Assessing Late Clinical Endpoints in Prostate Cancer
    Publication number: 20200040400
    Abstract: The present disclosure relates to uses of a multiple gene-expression based Genomic Prostate Score™ (GPS™) algorithm for assessment of various clinical endpoints in prostate cancer patients, such as risks of clinical recurrence (CR), biochemical recurrence (BCR), distant metastasis (Mets), and prostate cancer death (PCD). In some embodiments, GPS result is determined for low and intermediate risk prostate cancer patients in order to assist in determining treatment strategies for those patients.
    Type: Application
    Filed: February 12, 2018
    Publication date: February 6, 2020
    Applicant: Genomic Health, Inc.
    Inventors: Ruixiao LU, Michael CRAGER, Nan ZHANG, Tara MADDALA, Phillip FEBBO, Hugh Jeffrey LAWRENCE
  • Hox-induced enhancement of in vivo and in vitro proliferative capacity and gene therapeutic methods
    Patent number: 5837507
    Abstract: Stem cells transduced with HOXB4 exhibit enhanced in vitro and in vivo ability for self-regeneration and generate higher-numbers of tranplantable pluripotent hematopoietic stem cells relative to control and nonmanipulated cells.
    Type: Grant
    Filed: November 13, 1995
    Date of Patent: November 17, 1998
    Assignees: The Regents of the University of California, Keith Humphries, Guy Sauvageau
    Inventors: Corey Largman, Hugh Jeffrey Lawrence, R. Keith Humphries, Guy Sauvageau